Incidental Mutation 'R8512:Irak4'
ID 655957
Institutional Source Beutler Lab
Gene Symbol Irak4
Ensembl Gene ENSMUSG00000059883
Gene Name interleukin-1 receptor-associated kinase 4
Synonyms 9330209D03Rik, 8430405M07Rik, IRAK-4, NY-REN-64
MMRRC Submission 067846-MU
Accession Numbers
Essential gene? Possibly non essential (E-score: 0.463) question?
Stock # R8512 (G1)
Quality Score 225.009
Status Not validated
Chromosome 15
Chromosomal Location 94441495-94466198 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to C at 94464659 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Isoleucine to Leucine at position 410 (I410L)
Ref Sequence ENSEMBL: ENSMUSP00000074471 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000074936] [ENSMUST00000109248]
AlphaFold Q8R4K2
PDB Structure Solution structure of the DEATH domain of Interleukin-1 receptor-associated kinase4 (IRAK4) from Mus musculus [SOLUTION NMR]
Molecular Structure of the Interleukin-1 Receptor-Associated Kinase-4 Death Domain [X-RAY DIFFRACTION]
Predicted Effect probably benign
Transcript: ENSMUST00000074936
AA Change: I410L

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000074471
Gene: ENSMUSG00000059883
AA Change: I410L

DomainStartEndE-ValueType
PDB:1WH4|A 1 114 1e-78 PDB
Pfam:Pkinase_Tyr 187 454 3.3e-53 PFAM
Pfam:Pkinase 187 456 4.9e-53 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109248
AA Change: I410L

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000104871
Gene: ENSMUSG00000059883
AA Change: I410L

DomainStartEndE-ValueType
Pfam:Death 20 101 1.6e-6 PFAM
Pfam:Pkinase_Tyr 187 452 1.9e-51 PFAM
Pfam:Pkinase 188 452 1.3e-54 PFAM
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.7%
  • 20x: 99.3%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
PHENOTYPE: Homozygous mutant mice exhibit defects of the innate immune system and show increased susceptibility to bacterial infection. [provided by MGI curators]
Allele List at MGI

All alleles(6) : Targeted(5) Chemically induced(1)

Other mutations in this stock
Total: 50 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adgre4 T C 17: 56,125,760 (GRCm39) probably null Het
Akap13 T C 7: 75,260,834 (GRCm39) S350P probably damaging Het
Celsr2 A G 3: 108,321,154 (GRCm39) F553L probably damaging Het
Ces3a A T 8: 105,784,661 (GRCm39) T548S probably benign Het
Chtf8 G A 8: 107,612,066 (GRCm39) T291I probably benign Het
Ckmt1 A T 2: 121,191,689 (GRCm39) R286S probably damaging Het
Dnajb2 C T 1: 75,218,075 (GRCm39) R191W Het
Dtnbp1 G T 13: 45,075,867 (GRCm39) A292E probably benign Het
Esrrg T G 1: 187,775,777 (GRCm39) Y101* probably null Het
Etaa1 G A 11: 17,897,442 (GRCm39) S225L probably damaging Het
Evi5l A G 8: 4,243,121 (GRCm39) Y335C probably benign Het
Fcho2 T C 13: 98,891,730 (GRCm39) D344G possibly damaging Het
Ggnbp2 C T 11: 84,728,815 (GRCm39) probably null Het
Gsdmc2 C T 15: 63,706,864 (GRCm39) V101I probably null Het
Gsdmc4 A G 15: 63,763,808 (GRCm39) C430R probably damaging Het
Kirrel1 A G 3: 86,995,534 (GRCm39) V436A probably benign Het
Lrrc30 T A 17: 67,938,947 (GRCm39) Q211L probably damaging Het
Map4k1 C T 7: 28,695,583 (GRCm39) H512Y possibly damaging Het
Matn3 T A 12: 9,011,183 (GRCm39) S365T probably benign Het
Msantd2 T C 9: 37,434,231 (GRCm39) I358T possibly damaging Het
Msantd5 T A 11: 51,125,487 (GRCm39) S137T probably benign Het
Msx3 G T 7: 139,628,884 (GRCm39) A10E probably benign Het
Muc16 T C 9: 18,549,488 (GRCm39) T5602A probably benign Het
Myh2 T C 11: 67,081,187 (GRCm39) S1268P probably benign Het
Mynn C T 3: 30,670,798 (GRCm39) P557S probably damaging Het
Naglu T C 11: 100,961,168 (GRCm39) V73A probably benign Het
Ncor1 AGCTGCTGCTGCTGCTGCTGCTGCTG AGCTGCTGCTGCTGCTGCTGCTG 11: 62,324,437 (GRCm39) probably benign Het
Or10al3 T A 17: 38,012,071 (GRCm39) F170Y probably damaging Het
Or6c75 T A 10: 129,337,496 (GRCm39) S240T probably damaging Het
P2rx3 C T 2: 84,854,755 (GRCm39) E100K probably damaging Het
Pnisr C T 4: 21,870,372 (GRCm39) Q375* probably null Het
Psmb9 C T 17: 34,402,602 (GRCm39) C126Y probably benign Het
Ptprt A G 2: 161,400,783 (GRCm39) F1085L probably benign Het
Rev3l A G 10: 39,697,534 (GRCm39) Y677C probably damaging Het
Rftn2 G A 1: 55,253,324 (GRCm39) P93L probably damaging Het
Rtl1 T A 12: 109,561,051 (GRCm39) M263L unknown Het
Sec24c T C 14: 20,740,920 (GRCm39) V722A possibly damaging Het
Slc2a7 T C 4: 150,247,752 (GRCm39) L384P probably benign Het
Slc6a11 T C 6: 114,215,402 (GRCm39) L434P probably damaging Het
Sptb T C 12: 76,648,826 (GRCm39) E1869G possibly damaging Het
Susd2 G A 10: 75,475,485 (GRCm39) T473I probably benign Het
Synpo C T 18: 60,735,483 (GRCm39) R821H probably damaging Het
Tdrd9 G A 12: 112,012,627 (GRCm39) V1184I probably benign Het
Tle1 T G 4: 72,040,670 (GRCm39) K630Q possibly damaging Het
Traf3 A T 12: 111,228,426 (GRCm39) T546S probably benign Het
Ttc17 G A 2: 94,202,108 (GRCm39) T398M probably damaging Het
Ttn G C 2: 76,698,692 (GRCm39) N136K Het
Ttn T C 2: 76,747,111 (GRCm39) E4646G probably benign Het
Xbp1 T C 11: 5,474,266 (GRCm39) S156P probably damaging Het
Yipf7 C T 5: 69,674,387 (GRCm39) V253I probably benign Het
Other mutations in Irak4
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00679:Irak4 APN 15 94,454,509 (GRCm39) missense probably benign 0.09
IGL00688:Irak4 APN 15 94,464,744 (GRCm39) missense possibly damaging 0.68
IGL01870:Irak4 APN 15 94,445,751 (GRCm39) missense probably benign 0.28
IGL02740:Irak4 APN 15 94,464,925 (GRCm39) makesense probably null
IGL02897:Irak4 APN 15 94,451,872 (GRCm39) missense probably benign 0.00
IGL03290:Irak4 APN 15 94,449,780 (GRCm39) missense probably benign 0.01
otiose UTSW 15 94,459,365 (GRCm39) missense probably damaging 1.00
R0057:Irak4 UTSW 15 94,451,753 (GRCm39) missense probably benign 0.00
R2010:Irak4 UTSW 15 94,449,687 (GRCm39) missense probably damaging 1.00
R3751:Irak4 UTSW 15 94,459,476 (GRCm39) missense probably damaging 1.00
R3752:Irak4 UTSW 15 94,459,476 (GRCm39) missense probably damaging 1.00
R3753:Irak4 UTSW 15 94,459,476 (GRCm39) missense probably damaging 1.00
R3973:Irak4 UTSW 15 94,452,621 (GRCm39) missense possibly damaging 0.73
R4687:Irak4 UTSW 15 94,464,704 (GRCm39) missense probably damaging 1.00
R4704:Irak4 UTSW 15 94,464,781 (GRCm39) splice site probably null
R5001:Irak4 UTSW 15 94,456,154 (GRCm39) missense possibly damaging 0.91
R5392:Irak4 UTSW 15 94,454,566 (GRCm39) missense probably benign 0.39
R5392:Irak4 UTSW 15 94,454,565 (GRCm39) missense probably benign
R6280:Irak4 UTSW 15 94,449,691 (GRCm39) nonsense probably null
R6390:Irak4 UTSW 15 94,459,367 (GRCm39) missense probably damaging 1.00
R7643:Irak4 UTSW 15 94,456,709 (GRCm39) missense probably benign 0.05
R8209:Irak4 UTSW 15 94,456,244 (GRCm39) missense probably damaging 1.00
R8222:Irak4 UTSW 15 94,459,110 (GRCm39) splice site probably null
R8226:Irak4 UTSW 15 94,456,244 (GRCm39) missense probably damaging 1.00
R8678:Irak4 UTSW 15 94,464,666 (GRCm39) missense probably benign 0.06
R9259:Irak4 UTSW 15 94,456,726 (GRCm39) missense probably damaging 1.00
R9287:Irak4 UTSW 15 94,460,917 (GRCm39) missense possibly damaging 0.93
R9685:Irak4 UTSW 15 94,451,812 (GRCm39) missense probably benign 0.22
V8831:Irak4 UTSW 15 94,459,365 (GRCm39) missense probably damaging 1.00
X0019:Irak4 UTSW 15 94,451,881 (GRCm39) missense probably benign 0.00
X0027:Irak4 UTSW 15 94,449,811 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- ATGTGTGCCTATGTATGCATTTCC -3'
(R):5'- AGCCGATGTCTTGAAATGGATAC -3'

Sequencing Primer
(F):5'- CTTTCGTAACATCTGACCTGTACAG -3'
(R):5'- TACTTAGTAAAGGATAAGGCACCAC -3'
Posted On 2020-10-20